ArticleGynecologic oncology2017

A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Danielle A Jandial et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.